Young‐Seung Kim

Improving Tumor-Targeting Capability and Pharmacokinetics of ^99mTc-Labeled Cyclic RGD Dimers with PEG₄ Linkers

Lijun Wang, Jiyun Shi, Young‐Seung Kim et al. · Molecular Pharmaceutics · 2008 · 144 citations · Full text

Medicine, Pharmacokinetics, Pharmacology +13

The IDO1 selective inhibitor epacadostat enhances dendritic cell immunogenicity and lytic ability of tumor antigen-specific T cells

Caroline Jochéms, Massimo Fantini, Romaine I. Fernando et al. · Oncotarget · 2016 · 142 citations · Full text

Life Sciences, Immunology, Pharmacology +17

Evaluation of a ^99mTc-Labeled Cyclic RGD Tetramer for Noninvasive Imaging Integrin α_vβ₃-Positive Breast Cancer

Shuang Liu, Wen‐Yuan Hsieh, Young Jiang et al. · Bioconjugate Chemistry · 2007 · 136 citations

Medicine, Oncology, Pharmacology +17

Improving Tumor Uptake and Pharmacokinetics of ⁶⁴Cu-Labeled Cyclic RGD Peptide Dimers with Gly₃ and PEG₄ Linkers

Jiyun Shi, Young‐Seung Kim, Shizhen Zhai et al. · Bioconjugate Chemistry · 2009 · 125 citations · Full text

Medicine, Nuclear Medicine, Pharmacology +17

Improving Tumor Uptake and Excretion Kinetics of ⁹⁹^mTc-Labeled Cyclic Arginine-Glycine-Aspartic (RGD) Dimers with Triglycine Linkers

Jiyun Shi, Lijun Wang, Young‐Seung Kim et al. · Journal of Medicinal Chemistry · 2008 · 109 citations · Full text

Medicine, Oncology, Pharmacology +15